PATENT CLAIM ANALYSIS

Application Number: 16271002
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-06
Patent Classification: ["424", "449000"]

Abstract:
A method and a non-rate controlled, monolithic, subsaturated patch for transdermally administering fentanyl and analogs thereof, for analgetic purposes, to a subject through skin over an extended period of time are disclosed.

Claim (Index 9):
The patch of  claim 8  wherein said fentanyl analog is selected from the group consisting of alfentanil, lofentanil, remifentanil and sufentanil.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 99.0
- Lexical Diversity: 1.19355
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['10420428', '13789587', '11888650', '14863688', '11665813']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8259438679512442
- 35 USC 102 Novelty (BERT): 0.5721451258925634
- Combined Prediction Score: 0.8005639937453761
- Mean Citation Score: 350.7553200000001
- Max Citation Score: 397.05286
- Similarity Product: 278.7250105509329

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test